Following the November 2016 election results, the future of healthcare reform hangs in the balance.
Republican control of the White House and Congress is expected to bring sweeping healthcare changes beginning in the earliest days of 2017. The Republican leadership has reiterated its intention to repeal and replace the Affordable Care Act (ACA), which also could include major reforms to the Medicare and Medicaid programs. Repeal of the ACA—whether in full or in part—would affect every health sector and stakeholder, including health insurers, manufacturers, laboratories, hospitals, providers, and most importantly, patients.
In addition to reforming the individual and small group health insurance markets and aspects of the group health insurance market, the ACA includes significant reforms to the Medicare and Medicaid programs. Examples of such reforms include filling the Medicare Part D “donut hole”, expanding Medicaid eligibility and creating both the Medicare Independent Payment Advisory Board and the Center for Medicare and Medicaid Innovation. In addition, the ACA amended the 340B drug pricing program, created a new approval pathway for biosimilar biological products, and established the Patient-Centered Outcomes Research Institute.
Sidley has assembled a dedicated task force that is closely monitoring all ACA-related developments. We will report on legislative and administrative proposals, as well as nominations and government investigations. We are ready to advise our clients on the impact of these developments and to assist in engaging and responding every step of the way.
News & Insights
- Centers for Medicare & Medicaid Services Releases “Market Stabilization” Proposed Rule; Comments Due March 7 – February 24, 2017
- Republican Senator Outlines Plan for Phased-In Repeal of Affordable Care Act Taxes – February 17, 2017
- Senators Urge Health and Human Services Secretary to Use Statutory Authority to Allow Drugs from Canada – February 17, 2017
- Senate Approves Rep. Tom Price for Department of Health and Human Services Secretary on Party Lines, 52-47 – February 10, 2017
- Medicare Payment Advisory Commission Focuses on Part B and Part D Reforms – February 9, 2017
- House Energy and Commerce Health Subcommittee Debates Two Medicaid Reform Bills – February 9, 2017
- White House Office of Management and Budget Issues Guidance on the “2 for 1” Executive Order; Lawsuit Follows – February 9, 2017
- Discussion of White House Office of Management and Budget Guidance on the “Regulatory Freeze Pending Review” Memo – February 9, 2017
- House Energy and Commerce Health Subcommittee Holds Hearing on Health Insurance Market Reforms on February 2, 2017 – February 3, 2017
- President Trump Issues Executive Order to Reduce Regulations and Regulatory Costs – February 2, 2017
- Pharmaceutical Industry Executives Meet with President Trump on January 31, 2017 – February 2, 2017
- Senate Finance Committee Advances Department of Health and Human Services Secretary Nominee Rep. Tom Price on February 1, 2017 – February 2, 2017
- House Energy and Commerce Health Subcommittee Holds Hearing on Medicaid Reform on February 1, 2017 – February 2, 2017
- Senate Health, Education, Labor and Pensions Committee Holds Hearing on the Individual Health Insurance Market on February 1, 2017 – February 2, 2017
- What Should Clinical Laboratories Expect in 2017? – February 2017
- Senate Health, Education, Labor and Pensions Committee Holds Hearing on Department of Health and Human Services Secretary Nominee Rep. Tom Price on January 18, 2017 – January 26, 2017
- Senate Finance Committee Holds Hearing on Department of Health and Human Services Secretary Nominee Rep. Tom Price on January 24, 2017 – January 26, 2017
- President Trump Issues Executive Order 13765 on the Affordable Care Act – January 24, 2017
- The House Republican Study Committee’s Affordable Care Act Repeal and Replace Legislation: The American Health Care Reform Act of 2017 – January 24, 2017
- Trump Administration Issues “Priebus Memo” Requiring Regulatory Freeze for Pending Regulations – January 20, 2017
- Health and Human Services Announces Acting Officials – January 18, 2017
- Congressional Budget Office Issues Report on Effects of Repealing Portions of the Affordable Care Act – January 2017
- ACA in the 115th Congress: “Repeal and Replace” Strategy Moves Forward But Faces Hurdles – January 2017
- President-elect Donald Trump’s HHS Landing Team Members – January 2017
- Rep. Tom Price (R-GA): President-elect Donald Trump’s Nominee for Secretary of the Department of Health and Human Services – January 2017
- Seema Verma, MPH: President-elect Donald Trump’s Nominee for Administrator of the Centers for Medicare & Medicaid Services – January 2017
- Election Results 2016: Preliminary Considerations for the Drug and Device Industry - November 17, 2016
- Election Results 2016: Preliminary Considerations for the Health Insurance Industry - November 15, 2016
Affordable Care Act Events
- On October 31, Sidley sponsored the symposium entitled “The Affordable Care Act: Trick or Treat?” to examine the Act’s five-year impact on the U.S. economy, political and legal landscape and medical outcomes. The event featured experts from the University of Chicago’s Booth School of Business, Harris School of Public Policy, Law School and Pritzker School of Medicine, as well as the University of Princeton and American Medical Association.
- “Mixing Policy and Politics: Opportunities and Challenges for our President-Elect,” Partnering for Cures, Dora Hughes, New York, NY November 14, 2016.
- “What does the Presidential Election mean for the Healthcare Community?” Illinois Biotechnology Innovation Organization, Dora Hughes, Chicago, IL December 7, 2016.
If you have any questions regarding ACA reform and how it might have an impact on your business, please contact the Sidley lawyer with whom you usually work, or
Senior Policy Advisor
+1 202 736 8653
Senior Policy Advisor
+1 202 736 8862
+1 202 736 8127
+1 202 736 8521
Healthcare and Food, Drug and Medical Device Compliance & Enforcement
+1 202 736 8349
+1 312 853 7101
+1 202 736 8785
+1 202 736 8322